Dis-Chem Faces Investor Uncertainty Amidst Leadership Transition and Strategic Pivot
The $1.7 billion South African pharmacy chain, Dis-Chem, is navigating a period of significant transition, marked by the impending retirement of its chairman and the current management’s ambitious rollout of…







